Company Overview

PRIME exits and American HealthCare Capital are pleased to exclusively present a U.S. based, state-of-the-art, FDA-approved, cGMP-certified, full-range laboratory facility seeking a strategic financial investor. The facility’s clients outsource their product formulary development (Pharmaceutical, Nutraceutical, and Cosmetics) via contract analytical testing services. As an affordable but technologically advanced outsourcing solution, the Company enables clients to develop multiple ranges of products including DEA-scheduled drugs (Class I-V and List I Chemicals) quickly and efficiently without the cost or the hassle associated with having an in-house laboratory.

The Opportunity

The founders and the management team of the Company, who have deep expertise in operating all segments of a CRO (Contract-Research-Organization), are seeking a strategic partner and a financial sponsor to help them use their existing laboratory as a stepping stone to expand their product offerings to include manufacturing and transition to becoming a CDMO (Contract Development Manufacturing Organization). The Seller of this FDA-approved U.S. pharma lab is open to all deal structures, including a majority control sale and a roll of equity, as well as an earn-out based on future sales. The asking price of this opportunity is to be determined and excludes cash, accounts receivable, and inventory.